A Prospective, Real-World, Interventional Study To Evaluate The Effect Of Mepolizumab On Achieving Clinical Remission In Participants With Severe Asthma
A Prospective, Real-World, Interventional Study To Evaluate The Effect Of Mepolizumab On Achieving Clinical Remission In Participants With Severe Asthma
This is a prospective, real-world, single arm, global, multi-centre study to evaluate the effect of timely treatment with mepolizumab (NUCALA) to achieve clinical remission in adult participants with severe asthma with an eosinophilic phenotype (SA-EP).
Inclusion Criteria:
Exclusion Criteria:
Hohenstein-Ernsttal, 9337, Germany
Monserrato CA, 09042, Italy
Pieve Di Soligo TV, 131044, Italy
?Od?, 90-153, Poland